TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · no major macro event
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

356.00$ -0.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,705 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ONC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
781 634 752 929 1,002 1,128 1,117 1,315 1,412 1,498 1,513 1,705 6,129
96 106 125 138 170 161 165 165 197 142 167 175 681
685 529 627 791 831 967 952 1,151 1,216 1,356 1,346 1,531 5,448
453 494 461 454 496 542 482 525 524 615 541 612 2,293
366 417 427 444 455 505 459 538 529 555 555 593 2,233
819 912 888 898 951 1,047 941 1,063 1,053 1,171 1,096 1,205 4,525
-134 -384 -261 -107 -120 -79 11 88 163 185 250 325 923
7.0 8.0 58 33 40
229 -351 -243 -106 -98 -85 21 100 147 149 259 312 868
14 17 7.7 14 23 67 20 5.2 22 83 32 75 212
215 -368 -251 -120 -121 -152 1.3 94 125 67 227 237 656
251 -327 -218 -82 -27 -35 61 135 184 249 333 393 1,159

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?